Your browser doesn't support javascript.
COVID-19 in patients with heart failure: the new and the old epidemic.
Sisti, Nicolò; Valente, Serafina; Mandoli, Giulia Elena; Santoro, Ciro; Sciaccaluga, Carlotta; Franchi, Federico; Cameli, Paolo; Mondillo, Sergio; Cameli, Matteo.
  • Sisti N; Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy nic.sisti@gmail.com.
  • Valente S; Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.
  • Mandoli GE; Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.
  • Santoro C; Department of Advanced Biomedical Sciences, Federico II University Hospital, Napoli, Italy.
  • Sciaccaluga C; Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.
  • Franchi F; Department of Medicine, Surgery and Neuroscience, Anesthesia and Intensive Care Unit, University of Siena, Siena, Italy.
  • Cameli P; Department of Medicine, Surgery and Neurosciences, Respiratory Diseases and Lung Transplantation, University of Siena, Siena, Italy.
  • Mondillo S; Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.
  • Cameli M; Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.
Postgrad Med J ; 97(1145): 175-179, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-691133
ABSTRACT
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has spread in nearly 200 countries in less than 4 months since its first identification; accordingly, the coronavirus disease 2019 (COVID 2019) has affirmed itself as a clinical challenge. The prevalence of pre-existing cardiovascular diseases in patients with COVID19 is high and this dreadful combination dictates poor prognosis along with the higher risk of intensive care mortality. In the setting of chronic heart failure, SARS-CoV-2 can be responsible for myocardial injury and acute decompensation through various mechanisms. Given the clinical and epidemiological complexity of COVID-19, patiens with heart failure may require particular care since the viral infection has been identified, considering an adequate re-evaluation of medical therapy and a careful monitoring during ventilation.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Failure Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Postgrad Med J Year: 2021 Document Type: Article Affiliation country: Postgradmedj-2020-138080

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Failure Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Postgrad Med J Year: 2021 Document Type: Article Affiliation country: Postgradmedj-2020-138080